Home › Funds › Parkman Healthcare Partners LLC › ANIP

Parkman Healthcare Partners LLC position in ANIP

ANI PHARMACEUTICALS INC · Health Care

Parkman Healthcare Partners LLC reported holding 185,855 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$13.5M, representing 1.22% of its reported portfolio and ranking #31 among its reported holdings. Parkman Healthcare Partners LLC has disclosed ANIP holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)185.85K sh
Reported value held$13.50M
Portfolio Weight1.22%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's ANIP position evolved

Parkman Healthcare Partners LLC first disclosed a stake in ANIP in Q3 2023 at 111,802 shares (US$6.5M). The position peaked in Q1 2026 at 280,575 shares, worth US$21.6M. Across 7 filings, Parkman Healthcare Partners LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 185,855 shares valued at US$13.5M — a reduction of -17,052 shares quarter over quarter.. Notable position changes include a 94% increase in Q1 2026 (shares rose 8% over the following quarter), a 28% trim in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 111.80K $6.49M New
Q1 2025 105.00K $7.03M New
Q2 2025 128.48K $8.38M Add
Q4 2025 145.00K $11.45M New
Q1 2026 280.57K $21.58M Add
Q2 2026 202.91K $16.80M Reduce
Q3 2026 185.85K $13.50M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANIP and 13F data

ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Deep Track Capital, LP (US$36.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIP

All ANIP fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held ANIP?

Parkman Healthcare Partners LLC has disclosed ANIP holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

What is Parkman Healthcare Partners LLC's current position in ANIP?

As of Q3 2026, Parkman Healthcare Partners LLC holds 185.85K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $13.50M, representing 1.22% of its reported portfolio and ranking #31.

Has Parkman Healthcare Partners LLC been buying or selling ANIP?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in ANIP. The position peaked in Q1 2026 at 280.57K shares.

Which other funds hold ANIP?

Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.